Dr Classe on Lymphadenectomy Omission in Advanced Epithelial Ovarian Cancer

Jean-Marc Classe, MD, PhD, discusses lymphadenectomy omission following cytoreductive surgery after chemotherapy in advanced epithelial ovarian cancer.

Jean-Marc Classe, MD, PhD, Nantes Université, discusses findings from the phase 3 CARACO trial (NCT01218490) investigating the omission of lymphadenectomy following cytoreductive surgery after neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer.